Anomalous decline of water transport in covalently modified carbon nanotube membranes

2011 ◽  
Vol 47 (27) ◽  
pp. 7683 ◽  
Author(s):  
Mainak Majumder ◽  
Ben Corry
Nanoscale ◽  
2018 ◽  
Vol 10 (27) ◽  
pp. 13242-13249 ◽  
Author(s):  
Xin Zhang ◽  
Wei Zhou ◽  
Fang Xu ◽  
Mingjie Wei ◽  
Yong Wang

Identifying the sources of interfacial resistance and depressing it by using an hourglass-shaped pore mouth.


Nano Letters ◽  
2013 ◽  
Vol 13 (5) ◽  
pp. 1910-1914 ◽  
Author(s):  
Jens H. Walther ◽  
Konstantinos Ritos ◽  
Eduardo R. Cruz-Chu ◽  
Constantine M. Megaridis ◽  
Petros Koumoutsakos

Nano Letters ◽  
2010 ◽  
Vol 10 (10) ◽  
pp. 4067-4073 ◽  
Author(s):  
Kerstin Falk ◽  
Felix Sedlmeier ◽  
Laurent Joly ◽  
Roland R. Netz ◽  
Lydéric Bocquet

2014 ◽  
Vol 16 (8) ◽  
pp. 082001 ◽  
Author(s):  
A Popadić ◽  
J H Walther ◽  
P Koumoutsakos ◽  
M Praprotnik

2009 ◽  
Vol 3 ◽  
pp. SART.S1050
Author(s):  
Caroline L. Strasinger ◽  
Nicole N. Scheff ◽  
Ji Wu ◽  
Bruce J. Hinds ◽  
Audra L. Stinchcomb

Transdermal systems are attractive methods of drug administration specifically when treating patients for drug addiction. Current systems however are deficient in therapies that allow variable flux values of drug, such as nicotine for smoking cessation or complex dosing regimens using clonidine when treating opioid withdrawal symptoms. Through the use of functionalized carbon nanotube (CNT) membranes, drug delivery to the skin can be controlled by applying a small electrical bias to create a programmable drug delivery system. Clearly, a transdermal patch system that can be tailored to an individual's needs will increase patient compliance as well as provide much more efficient therapy. The purpose of this paper is to discuss the applicability of using carbon nanotube membranes in transdermal systems for treatment of drug abuse.


Sign in / Sign up

Export Citation Format

Share Document